|
|
xi | |
About the editors |
|
xiii | |
Preface |
|
xv | |
Acknowledgments |
|
xvii | |
|
1 Cardiovascular pathology: guide to practice and training |
|
|
1 | (26) |
|
|
|
|
|
|
|
|
2 | (1) |
|
|
2 | (8) |
|
Genetics and molecular biology |
|
|
10 | (1) |
|
|
11 | (1) |
|
|
11 | (4) |
|
Heart transplant pathology |
|
|
15 | (1) |
|
Cardiovascular clinical diagnostic and imaging studies |
|
|
16 | (1) |
|
Training in cardiovascular pathology |
|
|
17 | (1) |
|
Cardiovascular pathologist roles as diagnostician, teacher, consultant, and care team member |
|
|
18 | (1) |
|
|
19 | (1) |
|
|
19 | (8) |
|
2 Anatomic considerations and examination of cardiovascular specimens (excluding devices) |
|
|
27 | (58) |
|
|
|
|
|
Gross examination of the heart |
|
|
28 | (17) |
|
Examination of surgical cardiovascular specimens |
|
|
45 | (4) |
|
Microscopic examination of the blood vessels and heart |
|
|
49 | (29) |
|
|
78 | (1) |
|
|
79 | (1) |
|
|
79 | (6) |
|
3 Age-related cardiovascular changes and diseases |
|
|
85 | (38) |
|
|
|
|
86 | (1) |
|
Nonspecific cardiovascular changes of aging |
|
|
86 | (8) |
|
Changes in the conduction system |
|
|
94 | (1) |
|
|
95 | (3) |
|
|
98 | (12) |
|
Genetic and molecular aspects of cardiovascular aging |
|
|
110 | (3) |
|
|
113 | (1) |
|
|
114 | (9) |
|
4 Fundamental principles in cardiovascular genetics |
|
|
123 | (26) |
|
|
|
|
123 | (1) |
|
|
123 | (1) |
|
|
124 | (3) |
|
Modern molecular diagnostics |
|
|
127 | (14) |
|
Identifying the genetic basis of cardiovascular disease |
|
|
141 | (2) |
|
Molecular diagnostics in cardiovascular pathology practice |
|
|
143 | (4) |
|
|
147 | (1) |
|
|
147 | (2) |
|
5 Pathophysiology of heart failure and an overview of therapies |
|
|
149 | (74) |
|
|
|
|
|
|
|
|
|
|
|
|
Overview of heart failure |
|
|
150 | (1) |
|
Clinical presentation and diagnostic criteria |
|
|
151 | (2) |
|
Pathophysiology of heart failure |
|
|
153 | (6) |
|
Neurohormonal alterations in heart failure |
|
|
159 | (12) |
|
|
171 | (3) |
|
Molecular responses and adaptation of cardiac cells |
|
|
174 | (3) |
|
Metabolic remodeling in heart failure |
|
|
177 | (9) |
|
Short- to intermediate-term circulatory support devices |
|
|
186 | (18) |
|
|
204 | (1) |
|
|
204 | (1) |
|
|
205 | (18) |
|
6 Congenital heart disease: pathology, natural history, and interventions |
|
|
223 | (42) |
|
|
|
|
223 | (1) |
|
|
224 | (1) |
|
|
224 | (1) |
|
|
224 | (2) |
|
|
226 | (3) |
|
Embryology of the cardiovascular system |
|
|
229 | (6) |
|
Clinical features and consequences |
|
|
235 | (1) |
|
Specific forms of congenital heart disease |
|
|
235 | (19) |
|
Surgical and nonsurgical interventions |
|
|
254 | (2) |
|
Congenital heart disease in the adult |
|
|
256 | (3) |
|
Natural history without and with interventions |
|
|
259 | (1) |
|
|
260 | (1) |
|
|
260 | (5) |
|
7 Vascular Pathobiology: Atherosclerosis and Large Vessel Disease |
|
|
265 | (42) |
|
|
|
|
Introduction to atherosclerosis |
|
|
265 | (1) |
|
Epidemiology and risk factors |
|
|
266 | (2) |
|
Gross and microscopic morphology of the fibroinflammatory lipid plaque |
|
|
268 | (3) |
|
Steps in atherosclerotic plaque formation and complications |
|
|
271 | (5) |
|
Cellular function and pathways in atherogenesis |
|
|
276 | (17) |
|
Nonatherosclerotic diseases of the aorta |
|
|
293 | (5) |
|
|
298 | (1) |
|
|
298 | (9) |
|
8 Diseases of small and medium-sized blood vessels |
|
|
307 | (46) |
|
|
|
307 | (1) |
|
Vascular activation and common vascular pathologic changes |
|
|
307 | (1) |
|
Congenital vascular diseases |
|
|
308 | (1) |
|
Genetic vascular disorders |
|
|
309 | (4) |
|
Endocrine/metabolic vascular disorders |
|
|
313 | (2) |
|
|
315 | (9) |
|
|
324 | (3) |
|
|
327 | (1) |
|
|
327 | (2) |
|
|
329 | (2) |
|
Vascular deposition disorders |
|
|
331 | (3) |
|
Intimal proliferative diseases |
|
|
334 | (2) |
|
|
336 | (2) |
|
|
338 | (3) |
|
|
341 | (3) |
|
|
344 | (1) |
|
|
344 | (9) |
|
9 Aneurysms of the aorta: ascending, thoracic, and abdominal and their management |
|
|
353 | (54) |
|
|
|
|
Maria E. Romero Andjagdish Butany |
|
|
|
353 | (1) |
|
Normal anatomy and histology of the aorta |
|
|
354 | (1) |
|
Aging changes of the aorta |
|
|
355 | (1) |
|
Thoracic aortic aneurysms |
|
|
355 | (5) |
|
Etiology and pathologic findings |
|
|
360 | (19) |
|
Clinical presentation and natural history |
|
|
379 | (1) |
|
Abdominal aortic aneurysm |
|
|
379 | (5) |
|
|
384 | (7) |
|
|
391 | (6) |
|
|
397 | (1) |
|
|
397 | (10) |
|
10 Myocardial ischemia and its complications |
|
|
407 | (40) |
|
|
|
|
|
|
407 | (1) |
|
Universal definition of myocardial infarction |
|
|
408 | (1) |
|
|
409 | (1) |
|
|
410 | (1) |
|
Biochemical changes with ischemia and biochemical markers |
|
|
411 | (1) |
|
Ultrastructural evolution of acute ischemic injury |
|
|
412 | (1) |
|
Cellular and subcellular mechanisms of myocardial injury |
|
|
413 | (2) |
|
Microscopic evolution of acute ischemic injury |
|
|
415 | (4) |
|
Morphology of coronary arteries and plaques |
|
|
419 | (1) |
|
Tako--Tsubo cardiomyopathy |
|
|
420 | (1) |
|
Gross evolution of acute ischemic injury |
|
|
421 | (1) |
|
Patterns of myocardial infarction |
|
|
422 | (1) |
|
Phenomena associated with ischemic injury |
|
|
423 | (3) |
|
Reperfusion of ischemic myocardium |
|
|
426 | (1) |
|
Complications of myocardial infarction |
|
|
427 | (5) |
|
Recognition and quantification of acute ischemic injury |
|
|
432 | (2) |
|
Pathology of interventions |
|
|
434 | (1) |
|
Pathophysiological and pharmacological interventions |
|
|
435 | (1) |
|
Genetics and molecular biology of ischemic heart disease |
|
|
436 | (1) |
|
Genetics of coronary artery disease |
|
|
436 | (1) |
|
Molecular biology of coronary artery disease |
|
|
437 | (1) |
|
Cell-based therapies for ischemic heart disease |
|
|
438 | (1) |
|
|
439 | (1) |
|
|
439 | (8) |
|
11 Pathology of sudden death, cardiac arrhythmias, and conduction system |
|
|
447 | (88) |
|
|
|
|
|
447 | (46) |
|
Cardiac conduction system |
|
|
493 | (18) |
|
|
511 | (6) |
|
Appendix guidelines for postmortem study of sudden death |
|
|
517 | (5) |
|
|
522 | (1) |
|
|
522 | (1) |
|
|
522 | (13) |
|
|
535 | (18) |
|
|
|
|
535 | (1) |
|
|
536 | (1) |
|
|
537 | (4) |
|
|
541 | (1) |
|
Coronary arteries and ischemia |
|
|
542 | (1) |
|
|
542 | (1) |
|
Specific drug considerations |
|
|
543 | (5) |
|
|
548 | (1) |
|
Myocardial toxins as a cause of death |
|
|
548 | (1) |
|
Genetics and molecular biology |
|
|
549 | (1) |
|
|
549 | (1) |
|
|
550 | (3) |
|
|
553 | (24) |
|
|
|
|
553 | (1) |
|
Definition of myocarditis |
|
|
554 | (1) |
|
|
555 | (2) |
|
Histopathologic patterns of myocarditis |
|
|
557 | (5) |
|
Etiologies of myocarditis |
|
|
562 | (8) |
|
|
570 | (1) |
|
Molecular and genetic technologies and considerations in myocarditis |
|
|
570 | (1) |
|
|
571 | (1) |
|
|
571 | (6) |
|
|
577 | (56) |
|
|
|
Definition and classification of cardiomyopathies |
|
|
578 | (1) |
|
|
579 | (9) |
|
Hypertrophic cardiomyopathy |
|
|
588 | (16) |
|
Arrhythmogenic cardiomyopathy |
|
|
604 | (9) |
|
Restrictive cardiomyopathy |
|
|
613 | (9) |
|
|
622 | (3) |
|
Genetics and molecular biology |
|
|
625 | (1) |
|
|
626 | (1) |
|
|
627 | (6) |
|
15 The pericardium and its diseases |
|
|
633 | (30) |
|
|
|
|
|
633 | (1) |
|
|
634 | (8) |
|
|
642 | (1) |
|
|
643 | (14) |
|
|
657 | (1) |
|
|
657 | (1) |
|
|
658 | (5) |
|
16 Valvular heart disease |
|
|
663 | (44) |
|
|
|
|
|
663 | (1) |
|
|
664 | (2) |
|
|
666 | (1) |
|
|
666 | (9) |
|
|
675 | (11) |
|
Nonrheumatic mitral stenosis |
|
|
686 | (4) |
|
Rheumatic mitral regurgitation |
|
|
690 | (1) |
|
Other causes of mitral regurgitation |
|
|
691 | (3) |
|
Tricuspid valvular dysfunction |
|
|
694 | (2) |
|
Pulmonary valvular dysfunction |
|
|
696 | (1) |
|
|
697 | (8) |
|
|
705 | (1) |
|
|
705 | (2) |
|
17 Cardiac valve replacement and related interventions |
|
|
707 | (54) |
|
|
|
|
708 | (11) |
|
Valve-related complications: clinical importance, morphology, secondary effects, and pathogenesis |
|
|
719 | (13) |
|
Other tissue valve substitutes |
|
|
732 | (4) |
|
Transcatheter valve implantation |
|
|
736 | (5) |
|
Valve repair and valve sparing procedures |
|
|
741 | (3) |
|
New developments and future considerations |
|
|
744 | (2) |
|
Pathologic considerations in analysis of heart valve substitutes |
|
|
746 | (5) |
|
|
751 | (1) |
|
Appendix. Some Heart valve prostheses approved by the FDA |
|
|
751 | (1) |
|
|
752 | (1) |
|
|
753 | (8) |
|
18 The pathology of cardiovascular interventions and devices for coronary artery disease, vascular disease, heart failure, and arrhythmias |
|
|
761 | (38) |
|
|
|
|
762 | (1) |
|
Endovascular therapies and myocardial revascularization |
|
|
762 | (14) |
|
Aortic and peripheral vascular replacement and reconstruction |
|
|
776 | (8) |
|
Cardiac assist and replacement |
|
|
784 | (3) |
|
|
787 | (6) |
|
|
793 | (1) |
|
|
793 | (6) |
|
19 Tumors of the cardiovascular system: heart and blood vessels |
|
|
799 | (46) |
|
|
|
|
|
Incidence and classification |
|
|
799 | (3) |
|
|
802 | (1) |
|
Reactive cardiac masses and pseudotumors |
|
|
802 | (4) |
|
|
806 | (2) |
|
Hamartomas and benign neoplasms |
|
|
808 | (1) |
|
Hamartomas of the cardiac muscle |
|
|
808 | (3) |
|
|
811 | (1) |
|
Benign tumors of the myofibroblastic tissue |
|
|
812 | (1) |
|
Miscellaneous benign fibrous tumors |
|
|
813 | (1) |
|
|
814 | (6) |
|
|
820 | (9) |
|
Primary neoplasms and genetics |
|
|
829 | (1) |
|
|
830 | (2) |
|
Sarcomas of the great vessels |
|
|
832 | (5) |
|
|
837 | (1) |
|
|
837 | (8) |
|
20 Pathology of cardiac transplantation |
|
|
845 | (44) |
|
|
|
|
General clinicopathologic considerations |
|
|
845 | (2) |
|
Pathology of the explanted recipient heart |
|
|
847 | (2) |
|
Pathology of the donor heart |
|
|
849 | (1) |
|
Pathology of the allograft |
|
|
850 | (17) |
|
Posttransplant lymphoproliferative disorders |
|
|
867 | (6) |
|
Causes of death in heart transplant recipients |
|
|
873 | (1) |
|
Heart transplantation in combination with other organs |
|
|
873 | (1) |
|
Pathological review of an endomyocardial biopsy |
|
|
874 | (4) |
|
Approach to the examination of a failed allograft |
|
|
878 | (1) |
|
Noninvasive molecular testing for cardiac allograft rejection |
|
|
879 | (1) |
|
|
879 | (1) |
|
|
880 | (1) |
|
|
880 | (9) |
|
21 Basic pathobiology of cell-based therapies and cardiac regenerative medicine |
|
|
889 | (22) |
|
|
|
|
890 | (1) |
|
The rise (and fall) of the myocardial regeneration hypothesis |
|
|
890 | (1) |
|
Classic descriptions of growth, hypertrophy and failure of the heart |
|
|
891 | (5) |
|
Contemporary overview of cardiomyocytes biology |
|
|
896 | (1) |
|
Contemporary perspectives on myocardial pathobiology |
|
|
897 | (1) |
|
Experimental studies of stem cell therapy |
|
|
898 | (4) |
|
Clinical studies and trials of stem cell therapy |
|
|
902 | (1) |
|
Challenges to the rationale for cardiac stem cell therapy |
|
|
903 | (1) |
|
Regulatory considerations |
|
|
903 | (1) |
|
Alternatives to exogenous stem cell therapy |
|
|
904 | (1) |
|
|
904 | (1) |
|
|
905 | (1) |
|
|
906 | (5) |
|
22 Forensic aspects of cardiovascular pathology |
|
|
911 | (30) |
|
|
|
|
Investigative information |
|
|
911 | (1) |
|
|
912 | (2) |
|
Cardiovascular pathology consultation |
|
|
914 | (1) |
|
Injuries of the heart and major vessels |
|
|
914 | (4) |
|
Primary diseases of the heart |
|
|
918 | (3) |
|
Infectious and inflammatory conditions affecting the heart |
|
|
921 | (2) |
|
Diseases of the cardiac valves |
|
|
923 | (1) |
|
Anomalies and diseases of the aorta and coronary arteries |
|
|
924 | (5) |
|
Systemic diseases affecting the heart and major vessels |
|
|
929 | (3) |
|
|
932 | (4) |
|
Sudden death following surgical and medical procedures |
|
|
936 | (1) |
|
Organ and tissue procurement |
|
|
936 | (1) |
|
|
937 | (1) |
|
|
937 | (4) |
Index |
|
941 | |